Intellectual Property India Publishes Patent Application for Antibody-Drug Conjugate Comprising Bispecific Antibody Specifically Binding To Cd20 And Cd22 And Uses Thereof

MUMBAI, India, July 7 -- Intellectual Property India has published a patent application (202617069780 A) filed by Ligachem Biosciences Inc. Kr-- on June 03, 2026, for Antibody-Drug Conjugate Comprising Bispecific Antibody Specifically Binding To Cd20 And Cd22 And Uses Thereof.

Inventors include Kim, Wihak; Oh, Hwan Hee; Song, Ho Young; and Chung, Chul-Woong.

The application for the patent was published on July 03, 2026, under issue no. 27/2026.

Abstract: The present disclosure relates to an antibody-drug conjugate (ADC) comprising a bispecific antibody specifically binding to CD20 and CD22, and compositions and uses of the ADCs for producing a drug for the treatment and/or treatment of diseases, more particularly, hyperproliferative and/...